awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35123203-2F15CAFA-3285-46D8-AF9A-78DB924EEE25
Q35123203-2F15CAFA-3285-46D8-AF9A-78DB924EEE25
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35123203-2F15CAFA-3285-46D8-AF9A-78DB924EEE25
Phase I/II study of gefitinib (Iressa(®)) and vorinostat (IVORI) in previously treated patients with advanced non-small cell lung cancer
P2860
Q35123203-2F15CAFA-3285-46D8-AF9A-78DB924EEE25
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35123203-2F15CAFA-3285-46D8-AF9A-78DB924EEE25
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
916b185e8a32e3110ad954d437d53eaa24c33fa3
P2860
Acquired resistance to EGFR inhibitors is associated with a manifestation of stem cell-like properties in cancer cells.